The liver has been suspected to be one of the major targets of dengue virus infection. Here, we detected increasing secretion of the chemokine RANTES (regulated upon activation, normal T cell expressed and secreted), which functions to recruit the immune cells, in dengue-virus-infected liver cells and patients. Three luciferase reporter genes with various deletions at the 5Ј-end of the RANTES promoter were constructed to explore the RANTES activation mechanism in human liver cells. The reporter gene was optimally activated by dengue-2 virus when the RANTES promoter contains the region from the transcription starting site (ϩ1) to the nucleotide at the Ϫ181 position. NF-IL-6 and an undefined factor forming DNA-protein complexes in the RANTES promoter E and A/B regions in the infected cells were demonstrated by electrophoretic mobility shift assay. Further analysis showed that oxidative stress was an upstream inducer of NF-IL-6 and RANTES signaling in dengue-virus-infected liver cells. This finding was demonstrated by three antioxidants (N-acetyl-L-cysteine, nitro-L-arginine methyl ester, and pyrrolidine dithiocarbamate) used to suppress the activation. In contrast, the DNA binding activity of the undefined factor was not affected by the antioxidant treatment, indicating the existence of an oxidantindependent pathway. We hypothesize that dengue virus infection of the liver cells may trigger both an oxidant-dependent and an oxidant-independent pathway to up-regulate RANTES mRNA expression through activating NF-IL-6 and an undefined factor, respectively. In conclusion, the present study suggests a new direction for the study of liver pathogenesis involving RANTES in host immune responses during dengue virus infection.
INTRODUCTION
Patients with dengue virus infection show a wide range of clinical syndromes, from mild fever to lifethreatening symptoms of hemorrhagic fever and/or shock syndrome (DHF/DSS) (Halstead, 1989) . The clinical features of DHF include plasma leakage, a tendency to bleed, and liver involvement (Rothman and Ennis, 1999) . Because the liver is the major organ synthesizing most of the hemostatic factors (such as fibrinogen and coagulation factors) (Pereira et al., 1996) , and because hemostatic abnormalities are involved during the progression of DHF/DSS (Hathirat et al., 1993) , the relationship between liver cells and DHF/DSS cannot be excluded. Clinical observations have detected dengue virus antigen in hepatocytes, and virus particles have been recovered from the liver biopsies of DHF patients (Burke, 1968; Halstead, 1989; Rosen et al., 1989; Couvelard et al., 1999) . Recently, a mouse model further confirmed that the liver plays a pathogenic role during dengue virus infection and might be one of the important targets for dengue virus infection . Extensive studies have concentrated on the relationship between dengue virus and monocytes, lymphocytes, or endothelial cells (Krishnamurti and Alving, 1989; Avirutnan et al., 1998; Hober et al., 1998) , but the relationship between dengue virus and liver cells has rarely been explored. In a previous report, however, we demonstrated that dengue-2 virus could replicate and cause evident cytopathic effects (CPE) in different liver cell lines (Lin et al., 2000) .
RANTES (regulated upon activation, normal T cell expressed and secreted), a member of the C-C chemokine family, was originally cloned from CD8 ϩ T lymphocytes (Schall et al., 1988) and has chemotactic activity for eosinophils (Rot et al., 1992) , basophils (Dahinden et al., 1994) , monocytes (Schall et al., 1990) , NK cells (Taub et al., 1995) , and T lymphocytes (Schall et al., 1990) . Infection of some viruses has been shown to induce RANTES expression in a wide variety of cells (Avirutnan et al., 1998; Matsukura et al., 1998; Thomas et al., 1998) . Thus, virus-induced RANTES expression could be a major element in the pathogenesis of viral infection. Increased RANTES secretion in dengue-virus-infected patients and liver cell lines was also found in this study.
RANTES could be activated differently by different stimuli, indicating a wide range of control at the transcriptional level (Nelson et al., 1993 (Nelson et al., , 1996 Moriuchi et al., 1997; Ortiz et al., 1997) . The 5Ј-region of the RANTES gene is divided into five regions (A-E) (Ortiz et al., 1997) . The A/B region contains a consensus NF-B binding site (Ϫ58 to Ϫ27 nt), which can bind the transcription factors including those of the NF-B-Rel family and non-Rel family (Nelson et al., 1996; Song et al., 1999) , and the E region contains a consensus NF-IL-6 binding site (Ϫ100 to Ϫ92 nt). NF-IL-6, a member of the basic leucine zipper protein family, containing the CCAAT/enhancer-binding protein (C/EBP) domain (Brasier and Kumar, 1994) , is responsible for the regulation of many acute-phase proteins and cytokines in hepatocytes (Matsusaka et al., 1993) . NF-IL-6 similar to some transcription factors could be regulated by oxidants when host cells responded to different types of inflammatory stimuli and caused an imbalance of the redox status (Jaspers et al., 1997 (Jaspers et al., , 1998 . It has been demonstrated that viral infection can activate the transcription factors and lead to the activation of specific cellular gene expression through alteration of the redox status (Mastronarde et al., 1995 (Mastronarde et al., , 1998 Knobil et al., 1998) . Whether dengue virus infection of liver cells can induce a similar host response has not been reported.
During the outbreak of dengue virus infection in southern Taiwan from Nov. 1998 to Jan. 1999, we detected higher RANTES levels in patients infected with dengue virus. In this study, we found a correlation between dengue virus infection and up-regulated RANTES gene expression in liver cells. Moreover, we found that the signal pathway of dengue-virus-induced RANTES production was associated with induced oxidative stress and the increased binding activity of NF-IL-6.
RESULTS

RANTES secretion is higher in patients with dengue virus infection
Serum samples from 12 patients infected with dengue-3 virus (3 with DHF/DSS and 9 with dengue fever (DF)) were analyzed for RANTES secretion by enzymelinked immunosorbant assay (ELISA) during the course of the fever. Because only limited patients with dengue virus infection were available, we conducted a WilcoxonMann-Whitney test to show that RANTES levels were significantly higher (P Ͻ 0.001) in patients with dengue virus infection (447.6 Ϯ 227.0 ng/ml) compared to patients with other febrile illness (OFI) plus hepatitis (88.1 Ϯ 115.2 ng/ml), with OFI only (60.8 Ϯ 33.9 ng/ml), with hepatitis only (7.8 Ϯ 12.0 ng/ml), and healthy controls (34.1 Ϯ 29.0 ng/ml) (P Ͻ 0.001) (Fig. 1) . No significant difference was detected between patients with DHF/DSS and DF (Table 1) . Correspondingly, all of these patients showed abnormally higher serum levels of liver transaminases (AST and ALT); nevertheless, no correlation between RANTES levels and liver transaminases was detected (Table 1) .
Dengue virus infection induces RANTES expression at protein and mRNA levels in liver cells
To test whether dengue virus infection of host cells induces RANTES secretion, we analyzed the RANTES level by ELISA in dengue-virus-infected cells. Table 2 shows that RANTES levels increased in dengue-2-and dengue-3-virus-infected Chang liver cells. Dengue-3 virus induced a lower level of RANTES secretion than dengue-2 virus. In liver cells without infection or with heat-inactivated-virus treatment, RANTES secretion was undetectable. Enterovirus 71 (EV-71) and coxsackievirus B3, which we found able to infect liver cells and cause CPE, could not induce RANTES secretion in liver cells (Table 2 ). In addition to Chang liver cells, dengue-2 virus infection induced RANTES secretion in other liver cell lines, including Hep3B and HuH-7. Dengue virus could also induce RANTES expression in the human microvascular endothelial cell-1 (HMEC-1) ( Table 2) .
To address the regulation of dengue-virus-induced RANTES secretion, we detected RANTES expression at mRNA levels in dengue-virus-infected cells by Northern blotting using human RANTES cDNA as the probe. Because dengue-2 virus showed higher infectivity in the cell culture system than dengue-3 virus, we used dengue-2 virus in the following experiments to investigate the host responses. Three liver cell lines were infected with dengue-2 virus (100 m.o.i.) and the RNA was harvested at 42 h p.i. for detection of RANTES expression. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene expression was used as an internal control. Figure  2A shows that RANTES mRNA expression was evidently induced at 36 h p.i. and reached a very high level at 42 h p.i. in Chang liver, Hep3B, and HuH-7 cells. In our previous report (Lin et al., 2000) , dengue-virus-induced CPE in liver cells was observed initially at 36 h p.i. and became severe at 48 h p.i. Moreover, the virion production in dengue-virus-infected liver cells started after passing the eclipse phase (12 h p.i.) and increased to a plateau at 36 h p.i. The induction of RANTES expression was parallel to the virus-induced CPE and the kinetics of virus replication. This indicates the association between the dengue virus up-regulated RANTES expression and the virus infection. We tried to confirm our findings using primary liver cells. Because of the difficulty in culturing human primary liver cells, we utilized mouse primary liver cells in our study as a substitution. We found that mouse primary liver and brain cells could be infected by dengue-2 virus and induced to express RANTES by RT-PCR detection (Fig. 2B) . Collectively, both the protein and the mRNA levels of RANTES were obviously elevated in dengue-virus-infected cells. Activation of the RANTES reporter genes in the dengue-2-virus-infected liver cells
To clarify that dengue-2 virus infection increased the transcription of the RANTES gene, a luciferase reporter gene driven by a RANTES promoter was constructed, and the promoter activity was evaluated. Deletions by the restriction enzyme digestion (BamHI, SacI, and MspI) of the RANTES promoter region were made to generate the constructs with nucleotides Ϫ881, Ϫ181, and Ϫ79 to the transcription start site (ϩ1) and named pGL-A (Ϫ881 ϳ ϩ54), pGL-B (Ϫ181 ϳ ϩ54), and pGL-C (Ϫ79 ϳ ϩ54), respectively (Fig. 3A) . After transient transfection of the reporter plasmids, Chang liver cells were infected with either dengue-2 virus or heat-inactivated virus, and the cell lysates were harvested at 42 h p.i. for luciferase activity assay. Similar to heat-inactivated dengue virus, EV-71 could not activate the RANTES reporter plasmids, and it was used as a negative control. The luciferase activity of RANTES reporter genes pGL-A and pGL-B in the dengue-2-virus-infected cells was significantly higher than that of the heat-inactivated-virus-treated or EV-71-infected cells (P Ͻ 0.05) (Fig. 3B) . The pGL-A gene, which showed a lower luciferase activity than pGL-B, seems to contain a region for negative regulation of RANTES expression. The luciferase activity was lost in the reporter of pGL-C, indicating that the E region (Ϫ79 to Ϫ181) is critical for induction of RANTES expression.
The luciferase activity of the pGL-B reporter gene increased with infection time (1.5-fold at 24 h p.i. and 3.6-fold at 42 h p.i.) (Fig. 3C) , which was consistent with the increase in RANTES mRNA levels (Fig. 2) . Similarly, neither heat-inactivated virus nor mock infection activated the RANTES reporter gene. RANTES reporter gene activity was also induced in dengue-2-virus-infected Hep3B and HuH-7 cells (Fig. 3D ). Promoter activation between these cell lines was similar in pattern to the induction of RANTES protein secretion ( Table 2 ).
The formation of NF-IL-6-protein complex increases in dengue-2-virus-infected liver cells
We further identify the essential region in the RANTES promoter for the induction of RANTES expression by dengue-2 virus infection. The region between Ϫ181 to Ϫ79 nt of the RANTES promoter in the pGL-B reporter contains the consensus binding site for NF-IL-6 (Ϫ100 to Ϫ92 nt) (Nelson et al., 1993) . To determine whether the activation of the RANTES promoter is caused by binding of activated NF-IL-6 to the promoter, nuclear extracts from cells infected with either dengue-2 virus or heatinactivated virus were mixed with [␥- 32 P]ATP-labeled oligonucleotide of the NF-IL-6 binding site for an electrophoretic mobility shift assay (EMSA). Intensive bands representing a DNA-protein complex were observed in the dengue-virus-infected cells at 12, 24, and 36 h (Fig.  4A , lanes 4-6). The DNA-protein complex was NF-IL-6 specific, because a 100-fold excess of the same unlabeled oligonucleotide efficiently competed with the complex formation (Fig. 4B , lane 4), whereas an oligonucleotide containing the NF-B binding sequence (RANTES A/B site) failed to compete (Fig. 4B, lane 3) . NF-IL-6-specific antibody was also used to clarify the composition of the binding complex. Figure 4B shows that the FIG. 3 . Activation of RANTES promoter activity in dengue-2-virusinfected liver cells. (A) The RANTES promoter region was deleted by the restriction enzymes BamHI, SacI, and MspI to create the luciferase reporter plasmids pGL-A (Ϫ881 ϳ ϩ54), pGL-B (Ϫ181 ϳ ϩ54), and pGL-C (Ϫ79 ϳ ϩ54). (B) The three RANTES promoter reporters, pGL-A, pGL-B, and pGL-C (1 g), were transiently transfected into Chang liver cells in a 24-well plate using Lipofectin transfection reagent (BRL). The cells were infected with dengue-2 virus, heat-inactivated virus, or EV-71, and the luciferase activity of cell lysate was measured at 42 h p.i. The data shown represent the means of triplicate data, and the experiments were repeated three times. The data were analyzed by the WilcoxonMann-Whitney test (P Ͻ 0.05). (C) The pGL-B RANTES reporter gene was transiently transfected into Chang liver cells and treated with either dengue-2 virus for 24 and 42 h or heat-inactivated virus or mock infection (C) for 42 h. The cell lysates were harvested and analyzed as described in B. (D) The RANTES pGL-B reporter gene was transiently transfected into Hep3B, HuH-7, and Chang liver cells, which were then infected with either dengue-2 virus or heat-inactivated virus. The luciferase activities were analyzed at 42 h p.i.
NF-IL-6-protein complex was supershifted by the antibody against NF-IL-6/C/EBP␤ (lane 2), indicating specific binding by NF-IL-6. Moreover, the formation of binding complex with NF-IL-6 increased with infection time (Fig.  4A , lanes 4-6), which was consistent with the induction of RANTES promoter (Fig. 3C ), indicating the close relationship between NF-IL-6 and RANTES gene expression.
The formation of RANTES A/B-protein complex increases in dengue-2-virus-infected liver cells
We examined whether dengue virus would increase the binding activity for RANTES A/B site (Ϫ58 to Ϫ27 nt). Nuclear extracts from the cells infected with dengue-2 virus or inactivated virus were incubated with the [␥-
32 P]ATP-labeled oligonucleotide of the RANTES A/B site. Dengue-2 virus infection increased the formation of the RANTES A/B site-protein complex at 24 h p.i., suggesting the involvement of the A/B site during dengue virus infection (Fig. 5A, lane 5) . The A/B site-protein complex formed by TNF-␣ stimulation was used as a positive control (Fig. 5A, lane 7) . Heat-inactivated virus could not increase the A/B-protein complex (Fig. 5A,  lanes 1-3) . The unlabeled A/B oligonucleotide added at 100-fold excess into the reaction solution efficiently suppressed the complex formation (Fig. 5B, lane 4) , indicating that A/B site-protein complex formation is sequence specific.
The A/B site with the sequence homologous to the NF-B binding site could bind with diverse proteins, including members of the NF-B-Rel family. In the NF-B-Rel family, p65 and p50 heterodimers were formed in the dengue-virus-infected endothelial and hepatoma cells (Marianneau et al., 1997; Avirutnan et al., 1998) . Therefore, we investigated whether p65 and p50 subunits are responsible for the A/B site-protein complex in dengue-2-virus-infected liver cells. Figure 5B shows that when treated with TNF-␣, both anti-p65 and -p50 monoclonal antibodies recognized the A/B site-protein complex, which resulted in band shifting, indicating that p65 and p50 are involved in the A/B site-protein complex (Fig. 5B, lanes 7 and 8) . Another protein also bound to the A/B site, which was not affected by either anti-p65 or -p50 antibodies (Fig. 5B, lanes 7 and 8) . For dengue-2-virus-infected cells, anti-p65 and -p50 antibodies could not supershift the A/B site-protein complex, indicating that a factor other than p65 and p50 is responsible for the binding with the A/B site (Fig. 5B, lanes 2 and 3) . Our observation was further confirmed by competition analysis using unlabeled oligonucleotide from the NF-B binding site (derived from immunoglobulin promoter), which could not block formation of the A/B site-protein complex in dengue-2-virus-infected Chang liver cells (Fig. 5B, lane 5) .
The induction of RANTES mRNA expression by dengue-2 virus infection is inhibited by antioxidants
To evaluate whether the stimulated cellular gene expression by dengue virus infection was caused by induced oxidative stress, we detected the redox status of the dengue-virus-infected cells by measuring the ratio of oxidized glutathione and total glutathione (GSSG/GSH), an index of oxidative stress, in dengue-2-virus-infected Chang liver cells. Figure 6A shows that dengue-2 virus increased the GSSG/GSH ratio with infection time. A two-fold increase is reached at 42 h p.i. (heat-inactivated virus: 2.63%; dengue-2 virus: 5.22%), indicating that dengue-2 virus infection can induce oxidative stress in liver cells. Furthermore, we clarified whether the induction of RANTES expression by dengue-2 virus infection was through induced oxidative stress. Three different antioxidants were used: N-acetyl-L-cysteine (NAC), pyrrolidine dithiocarbamate (PDTC), and N-nitro-L-arginine methyl ester (L-NAME). GSH was combined with NAC to increase the latter's potency (Lomaestro et al., 1995) . Chang liver cells were infected with dengue-2 virus and treated with optimal doses of NAC plus GSH (Wakulich et al., 1997) , PDTC (Sumitomo et al., 1999) , and L-NAME (Ishii et al., 1997 ) (5 mM, 1.6 mM, 10 M, and 1 mM), respectively. These antioxidants were not toxic to the cells at these dosages. At 42 h p.i., the RNA was extracted for detection of RANTES mRNA by Northern blot analysis. Figure 6B shows that all of the antioxidants used effectively suppressed RANTES mRNA expression, indicating that oxidants may be involved in the induction of RANTES gene expression by dengue-2 virus infection (lanes 3-5).
Activation of NF-IL-6-protein complex formation by dengue-2 virus infection is suppressed by antioxidants
To further confirm our hypothesis that oxidative stress involves the activation of the transcription factor and the induction of RANTES expression by dengue-2 virus infection, NAC, L-NAME, and PDTC were used to study whether they could affect the activation of the binding complex with the NF-IL-6 or the RANTES A/B sites by dengue-2 virus infection. The same treatment as that described in Fig. 6B was applied to dengue-2-virus-infected cells, and the nuclear extracts were harvested at 24 h p.i. to determine the binding complex for the NF-IL-6 or the RANTES A/B sites. Figure 7 shows that the binding complex for the NF-IL-6 site was suppressed by these antioxidants (lanes 8-10) . In contrast, the binding complex for the RANTES A/B site was not affected by these antioxidants (Fig. 7, lanes 3-5) .
DISCUSSION
We are the first to report that chemokine RANTES was higher in patients infected with dengue-3 virus, as well as that RANTES mRNA and protein expression increased in dengue-2-virus-infected liver cells. Further investigation revealed that RANTES promoter activity was enhanced. The region between the nucleotide position Ϫ181 and the transcription initiation site (ϩ1) of the RANTES promoter containing the consensus NF-IL-6 and NF-B binding sites was essential for activation. In dengue-2-virus-infected cells, NF-IL-6 and an undefined transcription factor were activated to bind to this region. Moreover, the GSSG/GSH ratio increased in dengue-2-virus-infected liver cells. The antioxidants (NAC plus GSH, L-NAME, and PDTC) were able to suppress the formation of the NF-IL-6-protein complex as well as the up-regulation of RANTES gene expression, but not the binding activity of the undefined factor to the RANTES A/B site. We therefore propose a model in which dengue-2 virus infection could trigger at least two signal pathways. The first is oxidative stress, which induces an oxidant-dependent signal pathway through NF-IL-6 to modulate RANTES expression in the cells (Fig. 8) . The second is an oxidant-independent pathway, in which an undefined factor binds to the RANTES A/B site to upregulate the RANTES gene. Both factors seem to be required for full activation of RANTES gene expression (Fig. 8) .
It has been reported that infection of any serotype of dengue viruses causes similar clinical symptoms (Gubler, 1998) . The severity of dengue disease depends on the virulence of virus strains and the immune status of the human host. Because of the mutability of the RNA genome, dengue viruses change genetically when replicated in the host. The genetic changes will possibility increase virus replication, viremia, severity of disease, and epidemic potential (Gubler, 1998) . The dengue patients analyzed in this study were all confirmed to have dengue-3 virus infection. Both dengue-2 and dengue-3 viruses could induce RANTES expression in liver cells FIG. 8 . A model for the induction of RANTES expression by dengue-2 virus infection in the infected liver cells. Dengue virus infection of liver cells induces oxidative stress and activates NF-IL-6 binding to the RANTES promoter, which can be inhibited by antioxidants, including NAC, L-NAME, and PDTC. An undefined factor other than NF-B-Rel family proteins is also activated but through an oxidant-independent pathway to bind to the A/B site of the RANTES promoter. Both factors seem to be required for full activation of RANTES expression by dengue virus infection in liver cells. ( Table 2 ). Dengue-3 virus infectivity and virus titer, however, are much lower than those of dengue-2 virus in the cell culture system. To obtain significant cellular responses, we chose dengue-2 virus for the in vitro study. The induction of RANTES expression by other viruses was investigated as well. EV-71 and coxsackievirus B3 could infect liver cells and cause CPE, but could not induce RANTES secretion in liver cells, indicating that the induction of RANTES expression in liver cells was dengue virus specific. Moreover, dengue-2 virus could also induce RANTES expression in different types of cells, such as HMEC-1 and mouse primary liver and brain cells.
Some cytokines have been analyzed in this study. Briefly, MIP-1␤, another C-C chemokine, was induced. IL-6 and IL-8 were also inducible, but the induction levels were lower than that of RANTES. IL-10, IFN-␥, TGF-␤, IL-2, and IL-4 were undetectable, and IL-1␤ and TNF-␣ were constitutively expressed (data not shown). Comparatively, dengue virus infection of liver cells tended to induce C-C chemokine expression including the specific activation of RANTES expression. The significance between dengue virus and RANTES was demonstrated by the following: (1) Patients with dengue virus infection had increased RANTES secretion compared to other viral infections, and (2) Induction of RANTES secretion in liver cells was specific for dengue virus infection but not for EV-71 or coxsackievirus B3 infection. These results suggest that RANTES may be an important factor in the pathogenesis of dengue virus infection. RANTES secretion from dengue-virus-infected cells may recruit immune cells to the inflammation sites. The balance of virus elimination and tissue damage will determine the severity of the disease.
It has been reported that the IFN-␣ level increased in dengue fever patients and that activated lymphocytes could express IFN-␣ to inhibit dengue virus infection in normal cells (Kurane et al., 1987 (Kurane et al., , 1993 . Hepatocytes, however, produce undetectable levels of type I IFN after virus infection (Keskinen et al., 1999) . It is possible that liver cells with dengue virus infection may recruit lymphocytes through RANTES expression, and then the activated lymphocytes will increase the host defense against viral infection through production of type I IFN.
RANTES levels were significantly higher in patients with dengue virus infection compared to patients with non-dengue infections, and the patients with dengue infection also had increased liver transaminases in their serum. However, the correlation between RANTES and liver transaminase was not significant. It is probably that (1) the liver transaminases in the serum are secreted mainly by an injured liver and were induced by either the direct effect of virus infection or the host immune response. The direct effect was supported by our investigation that dengue virus actively replicated in liver cells and increased the release of liver transaminases (Lin et al., 2000) . (2) RANTES in serum, however, can be released by many sources, in addition to the liver. For example, we found that dengue-2 virus also induced RANTES expression in endothelial and brain cells. Therefore, accumulation of RANTES in serum does not represent damage of the liver. Nevertheless, our in vitro study proved that dengue virus infection could definitely induce RANTES expression in the liver cells.
Our data clearly demonstrate the relationship between NF-IL-6 and dengue virus up-regulated RANTES expression based on the following evidence: (1) The induction of RANTES promoter activity was lost after the deletion of the region containing the NF-IL-6 binding sequence (Fig.  3B) ; (2) The formation of the NF-IL-6-protein complex was activated in dengue-2-virus-infected cells and the activation occurred simultaneously with the induction of RANTES expression (Fig. 4A) ; and (3) RANTES expression and the formation of the NF-IL-6-protein complex were suppressed simultaneously by antioxidants (Figs. 6B and 7). It has been reported by many investigators that gene activation needs the synergistic control of two transcription factors (Mastronarde et al., 1996; Jaspers et al., 1997) . For example, NF-IL-6 together with NF-B could induce IL-8 expression in RSV-infected epithelial cells (Mastronarde et al., 1996) . Similarly, we found that NF-IL-6 and an undefined factor were activated to bind the RANTES promoter in dengue-2-virus-infected cells. The binding of the undefined factor to the A/B site alone was not sufficient to induce RANTES expression. Therefore, we suggest that induction of RANTES expression by dengue virus infection in liver cells needs the coordinate activation of at least two factors which bind to NF-IL-6 and the A/B site of the promoter.
It has been reported that NF-B binds to the A/B site of the RANTES promoter and is involved in the activation of RANTES promoter (Nelson et al., 1996; Moriuchi et al., 1997; Ray et al., 1997; Thomas et al., 1998) . Avirutnan et al. and Marianneau et al. also reported that the p65 and p50 subunits of NF-B were activated in dengue-2-virusinfected liver cells (Marianneau et al., 1997; Avirutnan et al., 1998) . Our analysis, however, showed that a factor other than NF-B heterodimer (p50 and p65) forms the A/B site-protein complex in dengue-virus-infected liver cells. This finding was clarified by using the NF-B inhibitor SN50 (containing the p50 NF-B subunit NLS), which inhibited the TNF-␣-activated RANTES expression but had no effect on RANTES expression activated by dengue-2 virus infection (data not shown). All of the data indicate that the factor responsible for binding with the A/B site is not NF-B. Recently, a non-Rel protein, RFLAT-1 (RANTES factor of late-activated T lymphocytes-1), bound to the A/B site was cloned and was confirmed to be a transactivator of the RANTES gene in T cells (Song et al., 1999) . Moreover, in IL-1␤-stimulated astrocytes, the transcription factors SP1 and SP3 also bound to the A/B site of the RANTES gene (Song et al., 1999) .
RFLA-1, SP1, and SP3 were possibly also involved in the formation of the A/B site-protein complex in liver cells. Further study is necessary to clarify this unknown factor.
The reason that the band intensity of the RANTES A/B site complex increased at 24 h but dropped at 36 h after dengue virus infection is probably that this DNA-protein complex is more liable to degradation than the NF-IL-6-complex (Fig. 5A, lane 6) . At a later stage of infection, when the host cell has been severely damaged by dengue virus infection, this protein complex for the RANTES A/B site may become vulnerable to degradation. Nevertheless, this protein complex binding to the A/B site seems not to play a pivotal role in dengue virus upregulated RANTES expression.
GSH functions to maintain the redox status of the cells and is a substrate of GSH peroxidase, which metabolizes GSH to its oxidized form (GSSG) and then converts H 2 O 2 to H 2 O to reduce generation of the hydroxyl radical (•OH). Thus, the increase of the GSSG/GSH ratio in the denguevirus-infected liver cells represents the induction of oxidative stress (Lomaestro and Malone, 1995; Hara et al., 1996) . Three distinct antioxidants were used in our study: (1) NAC, a free radical scavenger, is a cysteine prodrug for maintaining intracellular thiol concentration and replenishing GSH in deficiency status (Lomaestro and Malone, 1995) ; (2) L-NAME, an inhibitor of nitric oxide synthase (NOS) (Moroz et al., 1998) , can block the generation of ROS from NOS (Ishii et al., 1997) ; and (3) PDTC, an iron chelator, is a strong free radical scavenger (Wild and Timothy, 1999) . These antioxidants with different inhibition mechanisms could maintain the redox status as well as suppress dengue-virus-induced RANTES mRNA expression. We have detected virus replication in antioxidant-treated liver cells. Consistent with a previous report (Schweizer and Peterhans, 1999) , the antioxidants used could not inhibit dengue-2 virus replication (data not shown). These antioxidants also could not block dengue-2-virus-induced CPE. Therefore, we suggest that these antioxidants suppressed the dengue-2-virus-induced RANTES expression through the prevention of oxidative stress in the cells.
Exposure to ozone, a highly reactive oxidant gas, has been reported to be able to induce the DNA binding activities of NF-IL-6, which would further mediate the expression of IL-8 in respiratory epithelial cells (Jaspers et al., 1997 (Jaspers et al., , 1998 . Similarly, our results show that dengue-2-virus-induced RANTES expression is mediated by oxidative stress, which uses an unknown mechanism to activate NF-IL-6 and then up-regulates the RANTES promoter. It is the first evidence that dengue virus infection may induce oxidative stress, which initiates the signal transduction for chemokine RANTES expression. Nevertheless, two questions remain to be solved: (1) How does dengue virus affect the oxidative condition in the infected cell? Dengue virus replication probably inhibits cellular protein synthesis and subsequently reduces the steadystate synthesis of antioxidant enzymes. Moreover, active viral protein synthesis may disrupt the balance of the redox in the host cells (Schweizer and Peterhans, 1999) ; (2) How does the redox status increase the NF-IL-6 binding activity to the RANTES promoter? We have measured the protein level of nuclear NF-IL-6, but the expression was similar to the cells treated with either dengue virus or heat-inactivated virus (data not shown). It suggests that the dengue-virus-induced DNA binding activity of NF-IL-6 is not caused by the increase of protein expression and nuclear translocation. Phosphorylation of a threonine residue located just N-terminal to the DNA binding domain by a ras-dependent MAP kinase has been suggested to be responsible for NF-IL-6 activities (Nakajima et al., 1993) . Protein tyrosine kinase (PTK) and protein kinase A (PKA) activities were demonstrated as the early events in the signal transduction cascade mediating the ozone-induced activation of NF-B and NF-IL-6 as well as the release of IL-8 (Jaspers et al., 1997 (Jaspers et al., , 1998 . Whether PTK and PKA mediate the oxidativestress-induced NF-IL-6 activation in dengue-virus-infected liver cells is worthy of further research.
In summary, we propose that dengue-2 virus may induce oxidative stress, which up-regulates RANTES mRNA expression in liver cells through activating NF-IL-6 to bind to the promoter. An undefined factor was also activated and bound to the A/B site of the RANTES promoter through an oxidant-independent pathway (Fig.  8) . These two factors either contact directly or bind together through other unknown proteins to up-regulate RANTES expression. Our study provides the signal pathway for RANTES expression in dengue-2-virus-infected liver cells, which will shed light on the regulation of RANTES gene expression and pave the way for better control of RANTES-involved viral diseases.
MATERIALS AND METHODS
Human serum
Serum was collected from 12 patients infected with dengue virus (9 males and 3 females; age range: 4 to 37 years old). All had clinical symptoms of fever, rash, and bone pain, and all were hospitalized in National Cheng Kung University Hospital from Nov. 1998 to Jan. 1999. Anti-dengue ELISA-IgM or RT-PCR was performed to demonstrate dengue-3 virus infection by the National Quarantine Service Department of Health in Taiwan. Diagnosis of DHF/DSS was based on the clinical criteria established by the World Health Organization (World Health Organization, 1980) . All of these patients were IgM anti-HBc negative. Serum samples were collected during the course of their fever and stored at Ϫ70°C. Serum samples were also collected from age-matched individuals without antibodies against dengue virus, including: (1) 9 patients at the acute stage of other virus infections (other febrile illness) and with abnormally high AST and ALT levels, (2) 14 patients with OFI and normal AST and ALT levels, (3) 12 patients without febrile illness and with abnormally high AST and ALT levels, and (4) 10 healthy people (controls). All serum samples were tested in the same way for RANTES levels. All but the controls had a confirmed febrile illness and confirmed AST and ALT serum levels.
Cell lines and virus
Chang liver cells (a nonmalignant human liver epithelial cell line) (Matsuguchi et al., 1990; Kim et al., 1998; Amaro et al., 1999) and HuH-7 and Hep3B (human hepatoma cell lines) cells were cultured at 37°C in a 5% CO 2 incubator. The cells were maintained in Dulbecco's modified Eagle's medium (DMEM) (Gibco-BRL, Grand Island, NY), supplemented with 10% fetal bovine serum (FBS) (TRACE, Australia), penicillin (200 unit/ml), and streptomycin (100 g/ml). The HMEC-1 cells were passaged continuously in endothelial basal medium (Clonetics, Santa Ana, CA), supplemented with 10% normal human serum (Irvine Scientific, Santa Ana, CA) (Xu et al., 1994) . The primary liver and brain cells from neonatal of BALB/c mice were treated with 0.1% trypsin for 18 h and then cultured in DMEM containing 30% FBS.
For virus infection experiments, cells were adsorbed with dengue-2 virus at the titer of 100 m.o.i. at 37°C for 2 h. The cells were then washed three times with phosphate-buffered saline (PBS) and incubated at 37°C in the normal medium.
Dengue-2 virus (PL0146 isolated from Taiwan) and dengue-3 virus (739079A) were maintained in C6/36 cells. The titer was evaluated in BHK-21 cells by plaque assay (Liu et al., 1997) . Dengue-2 virus was used throughout the entire study at 100 m.o.i. Dengue-2 virus was heated at 56°C for 30 min as inactivated virus (Avirutnan et al., 1998; Marianneau et al., 1999) . EV-71 (strain 4643 isolated from a patient in Taiwan) (Ho et al., 1999) and coxsackievirus B3 (strain H0297 isolated from a patient in Taiwan) (Wang et al., 1998) were prepared from Vero cells.
ELISA for RANTES
Immunoreactive RANTES in serum or culture supernatant was determined using a commercial ELISA kit according to the manufacturer's instructions (Endogen, Woburn, MA).
RNA extraction
Total cellular RNA was extracted by guanidine isothiocyanate lysis buffer (4 M guanidine isothiocyanate, 25 mM sodium citrate, 50 mM 2-mercaptoethanol, and 0.5% sarkosyl). The solution was sequentially mixed with 1/10 vol of 3 M sodium acetate (pH 5.2), an equal volume of water-equilibrated phenol, and 1/5 vol of chloroform. After centrifugation at 14,000 rpm for 20 min, the aqueous phase was combined with 2.5 vol of 95% ethanol to precipitate the RNA. The resulting RNA was dissolved in diethyl pyrocarbonate water (Sigma, St. Louis, MO) and quantified by the absorbency at an optical density of 260 nm (Liu et al., 1997) .
Probes
An ApaI-and EcoRI-digested 317-bp fragment (Ray et al., 1997; Schall et al., 1988) of human RANTES cDNA (99-415) from pBSRANTES and a PstI-digested 1250-bp fragment of GAPDH cDNA from plasmid pIBI30GAPDH (Fort et al., 1985) were labeled with [␣-32 P]dCTP using a megaprime DNA labeling system (Amersham, Buckinghamshire, UK).
Northern blotting
Total cellular RNA (30 g) was denatured in glyoxal solution containing 1 M glyoxal and 10 mM sodium phosphate (pH 6.5) at 50°C for 1 h and electrophoresed in 1% agarose gel at 80 V, 40 mA, for 2 h. The RNA gel was then blotted to the Hybond-N membrane (Amersham) through sodium phosphate transferring buffer (25 mM, pH 6.5). The blot was treated with UV-cross linker (Spectrolinker, XL-1000, NY) and hybridized with the [␣-
32 P]dCTP-labeled probe (2 ϫ 10 6 cpm/ml) (Liu et al., 1997) .
RT-PCR
Total cellular RNA (1 g) was added with 0.5 M of oligo-dT or sense primer for dengue-2 virus cDNA and denatured at 70°C for 10 min. The RNA mixture was then incubated at 37°C for 50 min and mixed with 1ϫ firststrand buffer (Gibco-BRL), 0.5 mM dNTP, 10 M DTT, and 200 U of MMLV-reverse transcriptase (Gibco-BRL). The cDNA was further used for PCR amplification in the reaction solution of 0.2 mM dNTP, 0.2 M sense and antisense primers, 1ϫ reaction buffer (Kevin Science Technology, Brea, CA), and 1 unit of Biothermal DNA polymerase (Kevin Science Technology). The reaction was then performed in a PCR thermal cycler (PerkinElmer, OH) for 2 min at 94°C, followed by 30 cycles of 30 s at 94°C, 30 s at 51°C, 30 s at 72°C, and, finally, 10 min at 72°C (Liu et al., 1997) . The primers for detection were the following:
RANTES cDNA (101 bp) (Simecka, 1999) ; sense: 5Ј-CCACGTCAAGGAGTATTTCTACACC-3Ј; antisense: 5Ј-TCTTCTCTGGGTTGGCACACAC-3Ј; dengue-2 cDNA (419 bp) (Liu et al., 1997) ; sense: 5Ј-GATATGGGTTATTGGATGGA-3Ј; antisense: 5Ј-CTGATTTCCATCCCGTA-3Ј; ␤-actin cDNA (348 bp) (Bohn et al., 1994) ; sense: 5Ј-TGGAATCCTGTGGCATCCATGAAAC-3Ј; antisense: 5Ј-TAAAACGCAGCTCAGTAACAGTCCG-3Ј.
Transient transfection and luciferase assay
The human RANTES promoter region was obtained by PCR of the human genomic DNA and the sequence was confirmed by an automatic Procise sequencer (Applied Biosystem Inc., Foster City, CA). A StuI-and KpnI-digested 951-bp DNA fragment containing the entire RANTES promoter region from the PCR product was cloned into pSKII bluescript (Stratagene, La Jolla, CA). Double digestion was conducted to generate the following promoter regions: Ϫ881 (BamHI)/ϩ54 (KpnI), Ϫ181 (SacI)/ϩ54 (KpnI), and Ϫ79 (MspI)/ϩ54 (KpnI), which were subcloned into the pGL-3 Basic luciferase reporter gene plasmid (Promega, Madison, WI) and named pGL-A, pGL-B, and pGL-C, respectively (Fig. 3A) . The luciferase activities were determined by a dual-light luciferase and ␤-galactosidase reporter gene assay system (Tropix, Bedford, MA) using a luminometer (Minilumate LB 9506, Germany) (Liu et al., 1999) .
EMSA
The cells (2 ϫ 10 6 ) were collected by centrifugation at 12,000 rpm for 10 s and suspended in 400 l of ice-cold buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, and 1.5 mM MgCl 2 ) with a mixture of protease inhibitors (0.5 mM PMSF, 0.5 mM DTT, 2 g/ml leupeptin, 2 g/ml pepstain, 12 l/ml sodium orthovanadate, and 10 l/ml NaF) (Boehringer Mannheim, Roche, Palo Alto, CA). After incubation in ice for 10 min, the mixture was centrifuged at 12,000 rpm for 10 s. The pellet was suspended with 100 l of buffer B (20 mM HEPES, pH 7.9, 420 mM NaCl, 0.2 mM EDTA, 1.5 mM MgCl 2 , 25% glycerol, and the mixture of protease inhibitors) and incubated in ice for 20 min and then centrifuged at 14,000 rpm for 2 min at 4°C. The supernatant was aliquoted and stored at Ϫ70°C. The experiments were repeated at least three times. Nuclear extract (5 g) was incubated in a binding buffer containing 13 mM HEPES (pH 7.9), 50 mM NaCl, 0.1 mM EDTA, 0.5 mM DTT, 20 g/ml salmon sperm DNA, and 40 g/ml poly (dI-dC) (Amersham Pharmacia Biotech, Piscataway, NJ) in ice for 15 min, and then 0.3 ng of [␥- 32 P]ATP end-labeled double-stranded DNA oligonucleotides was added to the nuclear protein mixture at room temperature for 30 min. Isotope-labeled oligonucleotides with or without protein binding were separated by a 5% polyacrylamide gel. The following oligonucleotides were used:
RANTES A/B site: 5Ј-TTTTGGAAACTCCCCT-TAGGGGATGCCCCT CA-3Ј (Ray et al., 1997) ; NF-IL-6 binding site: 5Ј-TGCAGATTGTGCAATGTACG-3Ј (Mastronarde et al., 1996) ; NF-B binding site: 5Ј-AGTT-GAGGGGACTTTCCCAGGC-3Ј (Avirutnan et al., 1998) .
The competition assay was conducted by adding 100-fold excess of the unlabeled oligonucleotide to the nuclear extract mixture. For the supershift assay, 2 g of the desired antibody against NF-B subunit p50 (1191X; Santa Cruz Biotech, CA), p65 (372X; Santa Cruz Biotech.), or NF-IL-6/C/EBP␤ (SC-746X; Santa Cruz Biotech) was added to the binding mixture. The mixture was incubated in ice for 30 min before the labeled probe was added (Ray et al., 1997) .
GSH and GSSG assay
The total GSH levels were determined according to the method of Anderson (Anderson et al., 1985) . Briefly, cell pellets were washed with PBS and resuspended in 1% picric acid. Subsequently, samples were centrifuged at 14,000 rpm for 15 min. The supernatant was aliquoted into 5 and 100 l for GSH and GSSH detection, respectively. For GSH detection, a mixture containing 5 l of sample, 200 l of distilled water, 700 l of 0.3 mM reduced form of ␤-nicotinamideadenine dinucleotide phosphate, and 100 l of 6 mM 3-carboxyl-4-nitrophenyl disulfide was incubated at 30°C for 3 min. Finally, glutathione reductase (5 l of 200 U/ml) was added immediately before the absorbency was read. The rate of formation of 2-nitro-5-thiobenzoic acid reflecting the amount of total GSH was measured at 412 nm every 30 s for 2 min with a spectrophotometer (DU 640B: Beckman Instruments, Fullerton, CA). The total GSH levels in the samples were calculated from a standard curve according to the known amount of GSH versus the rate of formation of 2-nitro-5-thiobenzoic acid.
For GSSG detection, 100 l of sample was mixed with 2 l of 2-vinylpyridine (Acros, NJ) at room temperature for 30 min to destroy GSH, and the retained GSSG was assayed as the procedure for GSH (Hara et al., 1996; Nakamura et al., 1997) .
Reagents NAC, GSH, PDTC, and L-NAME were purchased from Sigma Chemical Co.
Statistical analysis
Statistical analyses were performed with StatXact-3 version 3.0.1 for Windows (Cytel Software corporation, Cambridge, MA). Comparisons between groups were made using the Wilcoxon-Mann-Whitney test. The difference was considered significant if P Ͻ 0.05. The correlation coefficients were calculated using Pearson's correlation coefficient. The correlation was considered significant if P Ͻ 0.05.
